Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs GNRC✓SelectedUSD · GNRCGSK vs GNRC performance historyLatest closeAs of-1.56%11/19
Stock and ETF performance explorer

GSK vs GNRC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+41.3%
GNRC return
-53.8%
Excess return
+95.1%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGNRCExcessAlpha
1D-1.6%-0.2%-1.4%-1.6%
7D-4.7%+6.3%-11.0%-4.8%
30D-4.7%+5.4%-10.1%-4.9%
3M-8.8%-2.7%-6.0%-8.8%
6M-4.6%-15.9%+11.3%-4.5%
YTD+1.0%+50.4%-49.4%-1.3%
1Y+6.9%+39.3%-32.4%+4.8%
3Y+52.5%+79.7%-27.2%+47.3%
All+41.3%-53.8%+95.1%+39.9%

Cumulative growth

Daily Returns

Daily percentage return beside GNRC.

Daily Out/Under-Performance

Portfolio return minus GNRC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GNRC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GNRC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling